Manuel Margot exits game with apparent wrist injury

Padres Diamondbacks Baseball
Getty Images
1 Comment

Padres outfielder Manuel Margot was pulled from Friday’s game after sustaining an injury on an attempted catch in the eighth inning. Margot laid out in center field to snare Cesar Hernandez‘s double, but appeared to injure his left wrist in the process. Little is known about the precise nature or severity of the injury so far, but Margot underwent an evaluation following the incident and should have a clearer picture of his recovery timetable soon.

It’s a disappointing turn of events for the 23-year-old outfielder, who finished the game batting .245/.312/.365 with 25 extra-base hits and a .677 OPS through 312 PA. This isn’t the first time he’s been sidelined with wrist issues this season; he hyperextended his left wrist on another diving catch back in mid-May, though he managed to successfully avoid the disabled list (and a lengthy setback) after taking a few days off. It’s not clear whether he’ll be that lucky a second time.

An unforeseen result of Margot’s departure in the eighth: The Padres were forced to insert catcher A.J. Ellis in left field for the first time, as they had already cycled through their remaining options on the bench. Ellis, whose last tryout in the outfield came during a two-inning stint in Double-A back in 2007, didn’t get the chance to show off his defensive chops, however, as Wil Myers gloved the inning-ending out several minutes after Margot was removed from the game. The Padres dropped their series opener to the Phillies, 11-5.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.